Pancreatic tumors in patients with lung malignancies: A spectrum of clinicopathologic considerations

Southern Medical Journal

Volumn 97, Issue 9, 2004, Pages 811-815

  Schwarz, Roderich E ^a   Chu, Peiguo G ^b   Grannis Jr , Frederic W ^b  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MEDICAL RECORD; MELANOMA; METASTASIS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; SMOKING; SURVIVAL TIME; VISCERAL METASTASIS;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KERATIN-7; KERATINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; SMOKING;

EID: 4544290512     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000118129.88401.DB     Document Type: Article

References (38)

1. Engeland A, Andersen A, Haldorsen T, et al. Smoking habits and risk of cancers other than lung cancer: 28 years' follow-up of 26,000 Norwegian men and women. Cancer Causes Control 1996;7:497-506.
2. Gold EB. Epidemiology of and risk factors for pancreatic cancer. Surg Clin North Am 1995;75:819-843.
3. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
4. Neugut AI, Ahsan H, Robinson E. Pancreas cancer as a second primary malignancy: a population-based study. Cancer 1995;76:589-592.
5. Epstein LM, Katz L, Tamir A, et al. Incidence of lung cancer in five towns in Israel, 1960-74. Isr J Med Sci 1984;20:27-32.
6. Darby SC, Whitley E, Howe GR, et al. Radon and cancers other than lung cancer in underground miners: a collaborative analysis of 11 studies. J Natl Cancer Inst 1995;87:378-384.
7. Price TF, Payne RL, Oberleitner MG. Familial pancreatic cancer in south Louisiana. Cancer Nurs 1996;19:275-282.
8. Maeno T, Satoh H, Ishikawa H, et al. Patterns of pancreatic metastasis from lung cancer. Anticancer Res 1998;18:2881-2884.
9. Barz H, Barz D, Klemm P. Distribution of lung cancer metastases: I. combination and frequency of organ metastases [in German]. Arch Geschwzdstforsch 1982;52:551-560.
10. Matsuno S, Kato S, Kobari M, et al. Clinicopathological study on hematogenous metastasis of pancreatic cancer. Jpn J Surg 1986;16:406-411.
11. Mattsson B, Rutqvist LE. Some aspects on validity of breast cancer, pancreatic cancer and lung cancer registration in Swedish official statistics. Radiother Oncol 1985;4:63-70.
12. Doring C, Lindlar F. Clinically a primary lung carcinoma: during autopsy metastasis of a pancreatic cancer [in German]. Med Welt 1969;8: 407-411.
13. Mishriki YY. Pancreatic carcinoma presenting as primary lung cancer. Postgrad Med 1990;87:107-108.
14. Johnson DH, Hainsworth JD, Greco FA. Extrahepatic biliary obstruction caused by small-cell lung cancer. Ann Intern Med 1985;102:487-490.
15. Yapp RG, Siegel JH. Unexplained biliary tract dilatation in lung cancer patients. Endoscopy 1992;24:593-595.
16. Onuigbo WI. Lung cancer metastasis to the pancreas and its surrounding lymph nodes. Br J Dis Chest 1966;60:152-155.
17. Inagaki H, Nakao A, Ando N, et al. A case of solitary metastatic pancreatic cancer from rectal carcinoma: a case report. Hepatogastroenterology 1998;45:2413-2417.
18. Ghoneim AH, Brisson ML, Fuks A, et al. Monoclonal anti-CEA antibodies in the discrimination between primary pulmonary adenocarcinoma and colon carcinoma metastatic to the lung. Mod Pathol 1990;3: 613-618.
19. Sheahan K, O'Brien MJ, Burke B, et al. Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies. Ant J Clin Pathol 1990;94:157-164.
20. Loy TS, Sharp SC, Andershock CJ, et al. Distribution of CA 19-9 in adenocarcinomas and transitional cell carcinomas: an immunohistochemical study of 527 cases. Am J Clin Pathol 1993;99:726-728.
21. Tot T. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors. Cancer 1999;85: 171-177.
22. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002;40:403-439.
23. Harlamert HA, Mira J, Bejarano PA, et al. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma. Acta Cytol 1998;42:1382-1388.
24. Khoor A, Whitsett JA, Stahlman MT, et al. Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. Hum Pathol 1999; 30:695-700.
25. Lau SK, Luthringer DJ, Eisen RN. Thyroid transcription factor-1: a review. Appl Immunohistochem Mol Morphol 2002;10:97-102.
26. Seki M, Tsuchiya E, Hori M, et al. Pancreatic metastasis from a lung cancer: preoperative diagnosis and management. Int J Pancreatol 1998; 24:55-59.
27. Luketich JD, Martini N, Ginsberg RJ, et al. Successful treatment of solitary extracranial metastases from non-small cell lung cancer. Ann Thorac Surg 1995;60:1609-1611.
28. Kim SH, Brennan MF, Russo P, et al. The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer 1998;82:389-394.
29. Harrison LE, Merchant N, Cohen AM, et al. Pancreaticoduodenectomy for nonperiampullary primary tumors. Am J Surg 1997;174:393-395.
30. Janes R Jr, Niederhuber JE, Chmiel JS, et al. National patterns of care for pancreatic cancer: results of a survey by the Commission on Cancer. Ann Surg 1996;223:261-272.
31. Velie EM, Schatzkin, A. Common environmental risk factors, in Neugut AI, Meadows AT, Robinson E (eds): Multiple Primary Cancers. Philadelphia, Lippincott Williams & Wilkins, 1999, pp 213-223.
32. Naunheim KS, Virgo KS, Coplin MA, et al. Clinical surveillance testing after lung cancer operations. Ann Thorac Surg 1995;60:1612-1616.
33. Younes RN, Gross JL, Deheinzelin D. Follow-up in lung cancer: how often and for what purpose? Chest 1999;115:1494-1499.
34. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-129.
35. Martini N, Rusch VW, Bains MS, et al. Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer. J Thorac Cardiovasc Surg 1999;117:32-38.
36. Lamont JP, Kakuda JT, Smith D, et al. Systematic postoperative radiologic follow-up in patients with non-small cell lung cancer for detecting second primary lung cancer in stage IA. Arch Surg 2002;137:935-940.
37. Okada S, Yoshimori M, Kakizoe T. Pancreatic cancer: medical aspects. Pancreas 1998;16:349-354.
38. Macari M, Rofsky NM, Naidich DP, et al. Non-small cell lung carcinoma: usefulness of unenhanced helical CT of the adrenal glands in an unmonitored environment. Radiology 1998;209:807-812.